September 12th 2025
Study author David Brousseau, MD, MS, explains the benefit of a child being able to go home after a sickle cell disease-associated ED visit.
Navigating the current shortages of pediatric ADHD medications
Understand how to naviate the current shortage of pediatric ADHD medications.
Evaluating prevalence of psychotropic medication in children with type 1 diabetes
October 10th 2023From 2006 to 2019, psychotropic medication use for those with type 1 diabetes (T1D) increased, leading investigators to call for risk-benefit studies, further evaluating effectiveness and improved diabetes care in this population.
Advancements in FDA approvals for pediatric obesity treatment
GLP-1 receptor agonists, used to treat diabetes, are now also being used for obesity in children and adolescents.